ScoreWhy is Century Therapeutics, Inc. ?
1
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 311.49%, its profits have risen by 87.1%
2
Reducing Promoter Confidence
- Promoters have decreased their stake in the company by -2.4% over the previous quarter and currently hold 7.16% of the company
- Promoters decreasing their stake may signify reduced confidence in the future of the business
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Century Therapeutics, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Century Therapeutics, Inc.
302.99%
-0.28
99.91%
S&P 500
14.9%
0.77
19.29%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
157.97%
EBIT Growth (5y)
5.91%
EBIT to Interest (avg)
-74.52
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.67
Sales to Capital Employed (avg)
0.17
Tax Ratio
8.88%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
48.40%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.48
EV to EBIT
-13.58
EV to EBITDA
-31.41
EV to Capital Employed
6.50
EV to Sales
2.72
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-47.85%
ROE (Latest)
-8.65%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend10What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -99.69% (YoY
NET SALES(9M)
Higher at USD 109.16 MM
NET PROFIT(9M)
Higher at USD 16.74 MM
-6What is not working for the Company
PRE-TAX PROFIT(Q)
At USD -27.42 MM has Fallen at -522.69%
NET PROFIT(Q)
At USD -27.42 MM has Fallen at -465.89%
Here's what is working for Century Therapeutics, Inc.
Net Sales
At USD 109.16 MM has Grown at 4,416.51%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (USD MM)
Net Sales
Higher at USD 109.16 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months
Net Sales (USD MM)
Raw Material Cost
Fallen by -99.69% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Century Therapeutics, Inc.
Pre-Tax Profit
At USD -27.42 MM has Fallen at -522.69%
over average net sales of the previous four periods of USD -4.4 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -27.42 MM has Fallen at -465.89%
over average net sales of the previous four periods of USD -4.85 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
